# Oscar Health, Inc.: financial statements, quarterly

OSCR · NYSE · CIK 1568651 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/oscr.md) · [Financials](/companies/oscr/financials.md) · [Filings](/companies/oscr/filings.md) · [Insiders](/companies/oscr/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/oscr/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [5.5](/filings/0001568651-24-000032.md) | [5.7 d](/filings/0001568651-26-000011.md) | [5.6](/filings/0001568651-25-000015.md) | [5.2](/filings/0001568651-25-000025.md) | [4.9](/filings/0001568651-25-000037.md) | [4.8 d](/filings/0001568651-26-000011.md) | [4.3](/filings/0001568651-26-000040.md) | [6.5](/filings/0001568651-26-000069.md) | [8.8](/filings/0001568651-25-000037.md) | [9.0 d](/filings/0001568651-26-000011.md) | [5.7](/filings/0001568651-26-000040.md) | [6.1](/filings/0001568651-26-000069.md) |
| Selling, general and administrative | $m | [326](/filings/0001568651-24-000032.md) | [364 d](/filings/0001568651-26-000011.md) | [394](/filings/0001568651-25-000015.md) | [435](/filings/0001568651-25-000025.md) | [460](/filings/0001568651-25-000037.md) | [466 d](/filings/0001568651-26-000011.md) | [483](/filings/0001568651-26-000040.md) | [534](/filings/0001568651-26-000069.md) | [522](/filings/0001568651-25-000037.md) | [511 d](/filings/0001568651-26-000011.md) | [706](/filings/0001568651-26-000040.md) | [691](/filings/0001568651-26-000069.md) |
| Operating income | $m | [(58.2)](/filings/0001568651-24-000032.md) | [(145) d](/filings/0001568651-26-000011.md) | [186](/filings/0001568651-25-000015.md) | [67.8](/filings/0001568651-25-000025.md) | [(48.4)](/filings/0001568651-25-000037.md) | [(148) d](/filings/0001568651-26-000011.md) | [297](/filings/0001568651-26-000040.md) | [(230)](/filings/0001568651-26-000069.md) | [(129)](/filings/0001568651-25-000037.md) | [(334) d](/filings/0001568651-26-000011.md) | [704](/filings/0001568651-26-000040.md) | [389](/filings/0001568651-26-000069.md) |
| Interest expense | $m | [6.1](/filings/0001568651-23-000056.md) | [6.2 d](/filings/0001568651-24-000006.md) | [5.9](/filings/0001568651-24-000015.md) | [6.0](/filings/0001568651-25-000025.md) | [5.8](/filings/0001568651-25-000037.md) | [6.0 d](/filings/0001568651-26-000011.md) | [6.0](/filings/0001568651-26-000040.md) | [5.8](/filings/0001568651-26-000069.md) | [6.9](/filings/0001568651-25-000037.md) | [(1.1) d](/filings/0001568651-26-000011.md) | [5.4](/filings/0001568651-26-000040.md) | [4.7](/filings/0001568651-26-000069.md) |
| Income tax | $m | [0.9](/filings/0001568651-24-000032.md) | [(0.8) d](/filings/0001568651-26-000011.md) | [1.0](/filings/0001568651-25-000015.md) | [4.6](/filings/0001568651-25-000025.md) | [2.1](/filings/0001568651-25-000037.md) | [(0.4) d](/filings/0001568651-26-000011.md) | [12.7](/filings/0001568651-26-000040.md) | [(5.0)](/filings/0001568651-26-000069.md) | [(1.8)](/filings/0001568651-25-000037.md) | [(0.2) d](/filings/0001568651-26-000011.md) | [19.8](/filings/0001568651-26-000040.md) | [21.2](/filings/0001568651-26-000069.md) |
| Net income | $m | [(65.4)](/filings/0001568651-24-000032.md) | [(150) d](/filings/0001568651-26-000011.md) | [177](/filings/0001568651-25-000015.md) | [56.2](/filings/0001568651-25-000025.md) | [(54.6)](/filings/0001568651-25-000037.md) | [(154) d](/filings/0001568651-26-000011.md) | [275](/filings/0001568651-26-000040.md) | [(228)](/filings/0001568651-26-000069.md) | [(137)](/filings/0001568651-25-000037.md) | [(353) d](/filings/0001568651-26-000011.md) | [679](/filings/0001568651-26-000040.md) | [362](/filings/0001568651-26-000069.md) |
| Diluted EPS | $ per share | [(0.29)](/filings/0001568651-24-000032.md) | not reported | [0.62](/filings/0001568651-25-000015.md) | [0.20](/filings/0001568651-25-000025.md) | [(0.22)](/filings/0001568651-25-000037.md) | not reported | [0.92](/filings/0001568651-26-000040.md) | [(0.89)](/filings/0001568651-26-000069.md) | [(0.53)](/filings/0001568651-25-000037.md) | not reported | [2.07](/filings/0001568651-26-000040.md) | [1.10](/filings/0001568651-26-000069.md) |
| Basic EPS | $ per share | [(0.29)](/filings/0001568651-24-000032.md) | not reported | [0.77](/filings/0001568651-25-000015.md) | [0.24](/filings/0001568651-25-000025.md) | [(0.22)](/filings/0001568651-25-000037.md) | not reported | [1.10](/filings/0001568651-26-000040.md) | [(0.89)](/filings/0001568651-26-000069.md) | [(0.53)](/filings/0001568651-25-000037.md) | not reported | [2.28](/filings/0001568651-26-000040.md) | [1.20](/filings/0001568651-26-000069.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [1.4](/filings/0001568651-24-000032.md) | [1.9](/filings/0001568651-26-000011.md) | [2.2](/filings/0001568651-25-000015.md) | [2.3](/filings/0001568651-25-000025.md) | [1.2](/filings/0001568651-25-000037.md) | [1.5](/filings/0001568651-26-000011.md) | [2.2](/filings/0001568651-26-000040.md) | [2.6](/filings/0001568651-26-000069.md) | [2.1](/filings/0001568651-25-000037.md) | [2.8](/filings/0001568651-26-000069.md) | [4.8](/filings/0001568651-26-000040.md) | [4.1](/filings/0001568651-26-000069.md) |
| Current assets | $bn | [3.0](/filings/0001568651-23-000056.md) | [3.1](/filings/0001568651-25-000008.md) | [3.5](/filings/0001568651-24-000015.md) | [3.4](/filings/0001568651-24-000023.md) | [2.4](/filings/0001568651-24-000032.md) | [2.8](/filings/0001568651-26-000011.md) | [3.8](/filings/0001568651-25-000015.md) | [4.3](/filings/0001568651-25-000025.md) | [3.8](/filings/0001568651-25-000037.md) | [4.6](/filings/0001568651-26-000069.md) | [7.8](/filings/0001568651-26-000040.md) | [9.4](/filings/0001568651-26-000069.md) |
| Total assets | $bn | [3.3](/filings/0001568651-23-000056.md) | [3.6](/filings/0001568651-25-000008.md) | [4.4](/filings/0001568651-24-000015.md) | [5.0](/filings/0001568651-24-000023.md) | [4.5](/filings/0001568651-24-000032.md) | [4.8](/filings/0001568651-26-000011.md) | [5.8](/filings/0001568651-25-000015.md) | [6.4](/filings/0001568651-25-000025.md) | [5.7](/filings/0001568651-25-000037.md) | [6.3](/filings/0001568651-26-000069.md) | [9.3](/filings/0001568651-26-000040.md) | [11.2](/filings/0001568651-26-000069.md) |
| Current liabilities | $bn | [2.1](/filings/0001568651-23-000056.md) | [2.4](/filings/0001568651-25-000008.md) | [3.0](/filings/0001568651-24-000015.md) | [3.5](/filings/0001568651-24-000023.md) | [3.0](/filings/0001568651-24-000032.md) | [3.5](/filings/0001568651-26-000011.md) | [4.1](/filings/0001568651-25-000015.md) | [4.9](/filings/0001568651-25-000025.md) | [4.0](/filings/0001568651-25-000037.md) | [4.9](/filings/0001568651-26-000069.md) | [7.1](/filings/0001568651-26-000040.md) | [8.7](/filings/0001568651-26-000069.md) |
| Total liabilities | $bn | [2.4](/filings/0001568651-23-000056.md) | [2.8](/filings/0001568651-25-000008.md) | [3.4](/filings/0001568651-24-000015.md) | [3.9](/filings/0001568651-24-000023.md) | [3.3](/filings/0001568651-24-000032.md) | [3.8](/filings/0001568651-26-000011.md) | [4.5](/filings/0001568651-25-000015.md) | [5.2](/filings/0001568651-25-000025.md) | [4.7](/filings/0001568651-25-000037.md) | [5.3](/filings/0001568651-26-000069.md) | [7.6](/filings/0001568651-26-000040.md) | [9.2](/filings/0001568651-26-000069.md) |
| Long-term debt | $bn | [0.3](/filings/0001568651-23-000056.md) | [0.3](/filings/0001568651-25-000008.md) | [0.3](/filings/0001568651-24-000015.md) | [0.3](/filings/0001568651-24-000023.md) | [0.3](/filings/0001568651-24-000032.md) | [0.3](/filings/0001568651-26-000011.md) | [0.3](/filings/0001568651-25-000015.md) | [0.3](/filings/0001568651-25-000025.md) | [0.7](/filings/0001568651-25-000037.md) | [0.4](/filings/0001568651-26-000069.md) | [0.4](/filings/0001568651-26-000040.md) | [0.4](/filings/0001568651-26-000069.md) |
| Shareholders' equity | $bn | [0.9](/filings/0001568651-23-000056.md) | [0.8](/filings/0001568651-25-000008.md) | [1.0](/filings/0001568651-24-000015.md) | [1.1](/filings/0001568651-24-000023.md) | [1.2](/filings/0001568651-24-000032.md) | [1.0](/filings/0001568651-26-000011.md) | [1.3](/filings/0001568651-25-000015.md) | [1.2](/filings/0001568651-25-000025.md) | [1.0](/filings/0001568651-25-000037.md) | [1.0](/filings/0001568651-26-000069.md) | [1.7](/filings/0001568651-26-000040.md) | [2.1](/filings/0001568651-26-000069.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(1,149) d](/filings/0001568651-24-000032.md) | [297 d](/filings/0001568651-26-000011.md) | [634](/filings/0001568651-25-000015.md) | [497 d](/filings/0001568651-25-000025.md) | [(500) d](/filings/0001568651-25-000037.md) | [347 d](/filings/0001568651-26-000011.md) | [879](/filings/0001568651-26-000040.md) | [509 d](/filings/0001568651-26-000069.md) | [(965) d](/filings/0001568651-25-000037.md) | [672 d](/filings/0001568651-26-000011.md) | [2,619](/filings/0001568651-26-000040.md) | [2,092 d](/filings/0001568651-26-000069.md) |
| Capital expenditure | $m | [6.5 d](/filings/0001568651-24-000032.md) | [6.1 d](/filings/0001568651-26-000011.md) | [6.0](/filings/0001568651-25-000015.md) | [7.6 d](/filings/0001568651-25-000025.md) | [7.6 d](/filings/0001568651-25-000037.md) | [6.8 d](/filings/0001568651-26-000011.md) | [9.0](/filings/0001568651-26-000040.md) | [9.3 d](/filings/0001568651-26-000069.md) | [9.0 d](/filings/0001568651-25-000037.md) | [9.1 d](/filings/0001568651-26-000011.md) | [8.8](/filings/0001568651-26-000040.md) | [11.8 d](/filings/0001568651-26-000069.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [213](/filings/0001568651-23-000056.md) | [217](/filings/0001568651-24-000015.md) | [219](/filings/0001568651-24-000023.md) | [223](/filings/0001568651-24-000032.md) | [294](/filings/0001568651-25-000015.md) | [304](/filings/0001568651-25-000025.md) | [243](/filings/0001568651-25-000037.md) | [306](/filings/0001568651-26-000040.md) | [256](/filings/0001568651-26-000069.md) | [259](/filings/0001568651-25-000037.md) | [330](/filings/0001568651-26-000040.md) | [333](/filings/0001568651-26-000069.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:43 ET. No prices; not investment advice.